captopril has been researched along with sq-11725 in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (26.09) | 18.7374 |
1990's | 2 (8.70) | 18.2507 |
2000's | 7 (30.43) | 29.6817 |
2010's | 8 (34.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Cosgrove, N; Kostis, JB; Moreyra, AE; Ruddy, MC; Schneider, S; Shindler, DM | 1 |
Freis, ED | 1 |
Ansuini, R; Belogi, M; Campolucci, G; Gaggi, S; Pupita, F; Pupita, G | 1 |
Chan, KC; Yeung, ES | 1 |
Popa, V | 1 |
Antoncecchi, E; Balestrazzi, M; Chiarappa, R; De Cesaris, R; Ranieri, G | 1 |
Vidt, DG | 1 |
An, R; Chen, H; Gong, PL; Zen, FD; Zhang, YX; Zhu, ZH | 1 |
Hashimoto, A; Mori, T | 1 |
1 review(s) available for captopril and sq-11725
Article | Year |
---|---|
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
4 trial(s) available for captopril and sq-11725
Article | Year |
---|---|
Differential exercise effects of captopril and nadolol in patients with essential hypertension.
Topics: Adult; Aged; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Exercise; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nadolol; Rest | 1992 |
Life quality in patients under hypotensive treatment.
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Female; Furosemide; Heart Rate; Humans; Hypertension; Male; Nadolol; Patient Compliance; Quality of Life | 1987 |
Captopril-related (and -induced?) asthma.
Topics: Asthma; Captopril; Drug Combinations; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Triamterene | 1987 |
Effects of captopril and nadolol on renal hemodynamics in patients with essential hypertension.
Topics: Adult; Captopril; Cardiac Output; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Renal Circulation; Single-Blind Method | 1994 |
18 other study(ies) available for captopril and sq-11725
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Age and antihypertensive drugs (hydrochlorothiazide, bendroflumethiazide, nadolol and captopril).
Topics: Adult; Aged; Aging; Bendroflumethiazide; Black People; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Random Allocation; White People | 1988 |
Comments on enhanced peak responses due to solvent interaction.
Topics: Bendroflumethiazide; Captopril; Chromatography, Liquid; Nadolol; Solvents | 1987 |
[Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril].
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines | 1986 |
Direct positive chronotropic action by angiotensin II in the isolated mouse atrium.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dose-Response Relationship, Drug; Heart; Heart Atria; Heart Rate; In Vitro Techniques; Isoproterenol; Losartan; Male; Mice; Mice, Inbred C57BL; Nadolol; Stimulation, Chemical; Vasoconstrictor Agents | 2006 |